wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q27022567-B814F809-AAF1-47F9-91E1-E669B9EC28F1
Q27022567-B814F809-AAF1-47F9-91E1-E669B9EC28F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27022567-B814F809-AAF1-47F9-91E1-E669B9EC28F1
Recent progress in pharmaceutical therapies for castration-resistant prostate cancer
P2860
Q27022567-B814F809-AAF1-47F9-91E1-E669B9EC28F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27022567-B814F809-AAF1-47F9-91E1-E669B9EC28F1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0590cc44a59368a3d660943d89a30655ab54f8c6
P2860
Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.